Wednesday, September 2, 2026 See who Washington just made rich Get the free brief →
Money Racket
Who Cashes In When Washington Moves
TECHAccenture Wins $30M DOE Modernization ContracttodayENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk4 weeks agoDEFENSETrump Scales Back Korea Exercises—Defense Contractors Face UncertaintytodayTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze4 weeks agoWHITE HOUSETrump Bans Foreign Grid Equipment—US Suppliers WintodayHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win4 weeks agoENERGYDOE Stays Clean Energy Building Rules—Fossil Fuel Lobby Wins ReprievetodayHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure4 weeks agoHEALTHCARE & FDAFDA Approves Lisraya for Dermatomyositis—Rare-Disease WinyesterdayHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief4 weeks agoMARKETSFDIC Eases Reciprocal Deposit Rules—Bank Funding WinyesterdayTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone4 weeks agoMARKETSFTC Sues Amazon Over Ad Auction Manipulation—AntitrustyesterdayDEFENSERising Defense Spending Lifts Northrop Grumman Outlook4 weeks agoENERGYTrump Admin Fast-Tracks Alaska Oil Pipeline—Energy WinyesterdayMARKETSFTC Threatens Booking Holdings Over Priceline Practices4 weeks agoCRYPTOSEC Proposes Tailored Crypto Offering Rules—Clarity WinyesterdayHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices4 weeks agoDEFENSEBoeing Wins $131B F-15 Contract—Fighter Jet Dominance2 days agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma4 weeks agoCRYPTOSEC Proposes Crypto Offering Exemptions—Regulatory Clarity2 days agoTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout4 weeks agoENERGYCentrus HALEU Enrichment Wins Policy Tailwind—Nuclear Fuel2 days agoTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing4 weeks agoHEALTHCARE & FDAWhat Is a PDUFA Date?2 days agoWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers4 weeks agoMARKETSWhat Is a Negotiated Price2 days agoENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes3 weeks agoHEALTHCARE & FDAFDA Approves Mimrylo for Polycythemia Vera4 days agoDEFENSEPentagon Awards Space-Based Target Tracking Contracts3 weeks agoHEALTHCARE & FDAFDA Authorizes Generic Bimectin for Screwworm Prevention4 days agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio3 weeks agoHEALTHCARE & FDAFDA Opens GenAI Medical Device Regulation to Public Input4 days agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty3 weeks agoHEALTHCARE & FDATrump Admin Blocks $1.6B in Fraudulent Medicare Lab Payments4 days agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains3 weeks agoTECHNHTSA Extends Comment Period on Vehicle Safety Exemptions4 days agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift3 weeks agoENERGYBLM Launches 30-Year Permit for Trans-Alaska Pipeline Operations5 days agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacing3 weeks agoMARKETSFTC Blocks Henkel's $725M Liquid Nails Bid—Antitrust Wins5 days agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidance3 weeks agoHEALTHCARE & FDAFDA Approves First RAS Inhibitor for Pancreatic Cancer6 days agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Cask3 weeks agoDEFENSEBoeing Lands $131B F-15 Contract—Fighter Jet Dominance6 days agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestock3 weeks agoHEALTHCARE & FDACostco Enters Medicare Advantage—Retail Disruption Looms6 days agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contract3 weeks agoTRADE & TARIFFSTrump's 50% Canada Tariffs Take Effect—Retailers Brace6 days agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibility3 weeks agoTRADE & TARIFFSU.S. Rolls Out Iran Sanctions—Oil Prices Slip6 days agoDEFENSEBlackSky Lands Multi-Year Satellite Contract3 weeks agoHEALTHCARE & FDAAbbott's Dual Glucose-Ketone Monitor Wins FDA Nodlast weekHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Wins3 weeks agoHEALTHCARE & FDARegeneron's Gene Therapy Wins First GSD Type Ia Approvallast weekTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makers3 weeks agoDEFENSEStryker Lands $100M Defense Contract—Combat Vehicle Boostlast weekTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refund3 weeks agoTRADE & TARIFFSWalmart Deploys $2.9B Tariff Refund Into Price Cutslast weekCRYPTOSEC Delays Crypto Rules—Uncertainty Persists3 weeks agoTRADE & TARIFFSTrump Lifts Ground Beef Tariffs—Ranchers Face Price Pressurelast weekTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings2 weeks agoWHITE HOUSETrump Kills Affirmative Action Rules—Contractors Face Compliance Shiftlast weekENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Path2 weeks agoHEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage Easeslast weekTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boost2 weeks agoWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance Costslast weekHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressure2 weeks agoWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut Compliancelast weekWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demand2 weeks agoTECHCHIPS Act Transforms Binghamton Into Semiconductor Hublast weekENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Eases2 weeks agoTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New Sanctionslast weekDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfall2 weeks agoTECHUtah Governor Signs Quantum Computing Initiative Orderlast weekHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopoly2 weeks agoDEFENSEFAA Engine Inspection Order Lifts MRO Stockslast weekHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnostics2 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast weekTECHCommerce Eases Drone Export Rules—U.S. Makers Win2 weeks agoHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demandlast weekDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervalued2 weeks agoTECHD-Wave Wins Canadian Quantum Funding for Annealinglast weekENERGYNewsom Passes Diablo Canyon Decision to Successorlast weekENERGYEnbridge Wins Federal Permit for Line 5 Tunnellast weekHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpaymentlast weekENERGYFederal Court Orders Enbridge Line 5 Removallast weekWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Personslast week
Healthcare & FDA

CMS's Site-Neutral and 340B Cuts Would Squeeze Hospital Systems and Hand Wins to Outpatient Rivals

A proposed CMS rule targeting hospital payment premiums and 340B drug discounts puts large health systems on defense.

Image: Money Racket
By at Money Racket · Jul 19, 2026

CMS has proposed reforms that would push Medicare toward site-neutral payments — eliminating the premium hospitals charge for outpatient services performed in hospital-owned clinics versus independent physician offices — and would cut reimbursement rates under the 340B drug discount program, which reached $100 billion in sales in 2025.

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Site-neutral payments would erase the billing premium that hospital-owned outpatient clinics have used to undercut independent rivals for years.

Who cashes in: Independent ambulatory surgery centers and physician-owned outpatient groups are the structural winners; they've long competed at a price disadvantage against hospital outpatient departments. Publicly traded ASC operators like Surgery Partners (SGRY) and United Surgical Partners (private, majority-owned by Tenet Healthcare THC) benefit as the payment gap narrows. On the 340B side, large pharmacy benefit managers and specialty pharmacies that sit outside the 340B program — including CVS Health CVS and Cigna/Evernorth (CI) — face less margin compression from 340B-subsidized competition.

Who's exposed: Large nonprofit and for-profit hospital systems are the direct losers. HCA Healthcare HCA, Tenet Healthcare THC, and Universal Health Services UHS all derive significant revenue from the outpatient premium that site-neutral rules would eliminate. Community health systems that rely heavily on 340B drug revenue — particularly safety-net hospitals — face a double hit. The American Hospital Association has already signaled legal challenges, so implementation is not guaranteed.

What to watch next: The comment period and any subsequent litigation will determine timing. Watch for HCA and Tenet management commentary on the magnitude of revenue at risk. If the rule survives legal challenge and is finalized, outpatient-focused operators like Surgery Partners could see a meaningful re-rating.

Source: original report ↗

Knowing who cashed in is only half the trade.

Every catalyst has a second move — the supplier, the sector, the part already priced in. Money Racket Pro hands you that read on every policy event, plus the pre-market brief six mornings a week, before the open.

Get the edge · $40/mo

Join the readers who get there before the financial press. Cancel anytime, one click.

Share

https://moneyracket.com/article/cms-proposes-site-neutral-340b-cuts-hospital-pressure/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Get the free brief The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Get the free brief →